iSensure
About iSensure
iSensure develops AI-driven wearable and implantable devices that enhance patient care by interpreting multi-modal signals for personalized treatment and failure prediction. Their patented technologies improve contrast delivery in imaging procedures and monitor ventriculo-peritoneal shunt function, reducing complications and the need for surgical revisions in pediatric patients.
<problem> Current methods for monitoring ventriculo-peritoneal (VP) shunt function in pediatric patients often rely on subjective clinical assessments and imaging, which may delay the detection of shunt malfunction and increase the risk of complications. Existing contrast delivery methods in imaging procedures may not be optimal for all patients, potentially affecting image quality and diagnostic accuracy. </problem> <solution> iSensure is developing AI-powered wearable and implantable devices designed to improve patient outcomes through enhanced monitoring and personalized treatment. Their technologies focus on interpreting multi-modal signals to predict device failure and optimize contrast delivery in imaging. Specifically, they are working to improve the monitoring of VP shunt function, aiming to reduce complications and the need for surgical revisions in pediatric patients. By leveraging AI, iSensure seeks to provide clinicians with more timely and accurate information, enabling proactive interventions and improved patient care. </solution> <features> - AI-driven wearable devices for continuous, non-invasive monitoring of physiological signals - Implantable sensors that provide real-time data on device performance and patient health - Patented technologies for improved contrast delivery during imaging procedures - Predictive algorithms that identify potential device failures before they occur - Wireless data transmission for remote monitoring and analysis - Integration with electronic health records (EHRs) for seamless data sharing </features> <target_audience> The primary target audience includes pediatric neurosurgeons, radiologists, and hospitals specializing in the treatment of hydrocephalus and other conditions requiring VP shunts, as well as imaging centers seeking to optimize contrast delivery. </target_audience>
What does iSensure do?
iSensure develops AI-driven wearable and implantable devices that enhance patient care by interpreting multi-modal signals for personalized treatment and failure prediction. Their patented technologies improve contrast delivery in imaging procedures and monitor ventriculo-peritoneal shunt function, reducing complications and the need for surgical revisions in pediatric patients.
Where is iSensure located?
iSensure is based in Pasadena, United States.
When was iSensure founded?
iSensure was founded in 2022.
Who founded iSensure?
iSensure was founded by Jacob Agris.
- Jacob Agris - Chief Medical Officer and Founder
- Location
- Pasadena, United States
- Founded
- 2022
- Employees
- 2 employees